Pride Capital Partners realizes exit of KAIROS to US listed IQVIA

KAIROS offers a unique combination of biobanking and clinical trial management software to European and North American university hospitals and research centers.

www.kairos.de

KAIROS in a nutshell

2018
Investment year
> 40
Number of FTE
29 out of 35
German university hospitals use KAIROS software
3
Offices

Add-on acquisitions

No items found.

Interested?

Do you want to know what we can do for you? Contact us!

Tavga Khezer Lal

Office Manager
[email protected]